Antibodies.com wins 2026 King’s Award for International Trade

By AI, Created 11:14 AM UTC, May 20, 2026, /AGP/ – Antibodies.com has received a 2026 King’s Award for Enterprise in the International Trade category, the UK’s top business honour, after rapid overseas growth. The Cambridge life sciences company now supplies research reagents to scientists in more than 100 countries and says the award recognises its global expansion since 2015.

Why it matters: - The King’s Award for Enterprise is the UK’s most prestigious business honour. - The International Trade category recognises companies with exceptional overseas sales growth and sustained commitment to global trade. - The award can strengthen Antibodies.com’s visibility with researchers, biopharma customers, and global partners.

What happened: - Antibodies.com received a King’s Award for Enterprise in the International Trade category for 2026. - The Cambridge-based life sciences company was founded in 2015. - The company said the award reflects international growth since its founding. - Sebastian Newlove, company director, said the recognition marks a special moment for the team and validates the company’s focus on international growth and innovation in life science tools.

The details: - Antibodies.com says it has tripled its customer base over the past five years. - The company now supplies research reagents to scientists in more than 100 countries. - Antibodies.com serves more than 5,000 research institutions and biopharma companies worldwide. - The company’s portfolio includes more than 100,000 research reagents. - Products include antibodies, ELISA kits, recombinant proteins, and assay kits. - Antibodies.com says its products have been cited in more than 500 scientific journals. - The company provides PhD-level technical support. - Antibodies.com maintains logistics hubs in Cambridge, St Louis, and Stockholm. - The hubs support fast delivery to research institutions and biopharma companies across academia and industry. - The company supports biomedical research, drug discovery, and IVD development. - The award is valid for five years. - The King’s Award for Enterprise has recognised British businesses since 1965 and has been conferred on more than 7,000 companies.

Between the lines: - The award signals that international distribution has become a core part of Antibodies.com’s business model, not just a growth channel. - The company’s mix of broad reagent coverage, technical support, and logistics infrastructure suggests a push to serve global research customers at scale. - Newlove’s remarks frame the award as both validation and a platform for further growth.

What’s next: - Antibodies.com plans to build on the award and continue expanding its international reach. - The company said it hopes the recognition will draw more attention to its work supporting scientific research. - The company directs readers to more information about the award.

The bottom line: - Antibodies.com is using a major UK business award to underscore its rise from a Cambridge startup to a global research reagents supplier.